Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Obstet Gynecol. 2012 Oct;120(4):783–790. doi: 10.1097/AOG.0b013e318269c8bb

Fig. 1.

Fig. 1

Changes in contraception use over time in human immunodeficiency virus (HIV)-seropositive women. Contraceptive methods were divided into 6 mutually exclusive categories. Those using long-acting reversible contraceptive (LARC) and/or any other methods were placed in the “LARC” category; those using depot medroxyprogesterone acetate and/or any other methods, excluding LARC, were placed in the “DMPA” category; those using any form of PPR and/or any other methods, excluding LARC and DMPA, were placed in the “oral contraceptive pill, patch, or ring (PPR)” category; those using male condoms and/or any other methods, excluding LARC, DMPA and PPR, were placed in the “condom” category; those using any other method not previously accounted for were placed in the “others” category; those using no contraception were placed in the None category.